Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature

ONESTI, Concetta Elisa; Iacono, Daniela; Angelini, Silvia; Lauro, Salvatore; Mazzotta, Marco; Occhipinti, Mario Alberto; Giusti, Raffaele; Marchetti, Paolo

doi:10.21037/tlcr.2016.09.01

Article (Scientific journals)

Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature

ONESTI, Concetta Elisa; Iacono, Daniela; Angelini, Silvia et al.

2016 • In Translational Lung Cancer Research, 5 (6), p. 712-719

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/217496

DOI
10.21037/tlcr.2016.09.01

PubMed
28149766

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

tlcr-05-06-712case series.pdf

Publisher postprint (221.71 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Oncology

Author, co-author :

ONESTI, Concetta Elisa ; Sant'Andrea Hospital of Rome, Italy > Medical Oncology

Iacono, Daniela; Sant'Andrea Hospital of Rome, Italy > Medical Oncology

Angelini, Silvia; Sant'Andrea Hospital of Rome, Italy > Medical Oncology

Lauro, Salvatore; Sant'Andrea Hospital of Rome, Italy > Medical Oncology

Mazzotta, Marco; Sant'Andrea Hospital of Rome, Italy > Medical Oncology

Occhipinti, Mario Alberto; Sant'Andrea Hospital of Rome, Italy > Medical Oncology

Giusti, Raffaele; Sant'Andrea Hospital of Rome, Italy > Medical Oncology

Marchetti, Paolo; Sant'Andrea Hospital of Rome, Italy > Medical Oncology

Language :

English

Title :

Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature

Publication date :

December 2016

Journal title :

Translational Lung Cancer Research

ISSN :

2218-6751

eISSN :

2226-4477

Publisher :

AME Publishing Company, Hong Kong, China

Volume :

Issue :

Pages :

712-719

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 28 December 2017

Statistics

Number of views

77 (1 by ULiège)

Number of downloads

120 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
Ramalingam S, Belani C. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist 2008;13 Suppl 1:5-13.
Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-72.
Sperduto PW, Kased N, Roberge D, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012;30:419-25.
Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995;13:8-10.
Timmerman RD, Bizekis CS, Pass HI, et al. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 2009;59:145-70.
Timmerman RD, Kavanagh BD. Stereotactic body radiation therapy. Curr Probl Cancer 2005;29:120-57.
Bonnette P, Puyo P, Gabriel C, et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 2001;119:1469-75.
Hu C, Chang EL, Hassenbusch SJ 3rd, et al. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Cancer 2006;106:1998-2004.
Gray PJ, Mak RH, Yeap BY, et al. Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival. Lung Cancer 2014;85:239-44.
Griffioen GH, Toguri D, Dahele M, et al. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors. Lung Cancer 2013;82:95-102.
Arrieta O, Villarreal-Garza C, Zamora J, et al. Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation. Radiat Oncol 2011;6:166.
Collen C, Christian N, Schallier D, et al. Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients. Ann Oncol 2014;25:1954-9.
Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006;94:982-99.
Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
Macdermed DM, Weichselbaum RR, Salama JK. A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Oncol 2008;98:202-6.
Villarreal-Garza C, de la Mata D, Zavala DG, et al. Aggressive treatment of primary tumor in patients with non-small-cell lung cancer and exclusively brain metastases. Clin Lung Cancer 2013;14:6-13.
Ashworth A, Rodrigues G, Boldt G, et al. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature. Lung Cancer 2013;82:197-203.
Ashworth AB, Senan S, Palma DA, et al. An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer. Clin Lung Cancer 2014;15:346-55.
Niibe Y, Chang JY, Onishi H, et al. Oligometastases/Oligo-recurrence of lung cancer. Pulm Med 2013;2013:438236.
Modi A, Vohra HA, Weeden DF. Does surgery for primary non-small cell lung cancer and cerebral metastasis have any impact on survival? Interact Cardiovasc Thorac Surg 2009;8:467-73.
Moazami N, Rice TW, Rybicki LA, et al. Stage III nonsmall cell lung cancer and metachronous brain metastases. J Thorac Cardiovasc Surg 2002;124:113-22.
Iwasaki A, Shirakusa T, Yoshinaga Y, et al. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor. Eur J Cardiothorac Surg 2004;26:488-93.
Detterbeck FC, Lewis SZ, Diekemper R, et al. Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:7S-37S.
Al-Shamy G, Sawaya R. Management of brain metastases: the indispensable role of surgery. J Neurooncol 2009;92:275-82.
Reynders K, Illidge T, Siva S, et al. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev 2015;41:503-10.
Yarchoan M, Lim M, Brahmer JR, et al. Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival. Cureus 2015;7:e409.
Uppal A, Ferguson MK, Posner MC, et al. Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs. Clin Exp Metastasis 2014;31:735-48.
De Ruysscher D, Wanders R, van Baardwijk A, et al. Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450). J Thorac Oncol 2012;7:1547-55.
Enders F, Geisenberger C, Jungk C, et al. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer. Clin Neurol Neurosurg 2016;142:72-80.
Lamm AF, Elaimy AL, Mackay AR, et al. Long-Term Survival of a Patient with Brainstem and Recurrent Brain Metastasis from Stage IV Nonsmall Cell Lung Cancer Treated with Multiple Gamma Knife Radiosurgeries and Craniotomies: A Case Report and Review of the Literature. Case Rep Oncol Med 2012;2012:621641.
Gomez DR, Blumenschein GR, Lee JJ, et al. Local consolidative therapy (LCT) to improve progression-free survival (PFS) in patients with oligometastatic non-small cell lung cancer (NSCLC) who receive induction systemic therapy (IST): Results of a multi-institutional phase II randomized study. J Clin Oncol 2016;34:abstr 9004.
Fleckenstein J, Petroff A, Schäfers HJ, et al. Longterm outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer. BMC Cancer 2016;16:348.
Leduc C, Antoni D, Quoix é, et al. Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report. Cancer Radiother 2015;19:192-7.
Lussier YA, Xing HR, Salama JK, et al. MicroRNA expression characterizes oligometastasis(es). PLoS One 2011;6:e28650.
Lussier YA, Khodarev NN, Regan K, et al. Oligo-and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One 2012;7:e50141.